The Efficacy of Silymarin as Adjuvant Therapy on Colorectal Cancer Patients Undergoing FOLFIRI Treatment

Primary objectives: Use both listed and relatively safe drug, Silymarin,s to improve the intestinal side effect of the patients undergoing FOLFIRI chemotherapy.

核心研究目标：采用获批上市且安全性良好的水飞蓟素（Silymarin），改善接受FOLFIRI化疗患者的肠道不良反应。